http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#Head http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#assertion http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#provenance http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#pubinfo http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#assertion http://purl.obolibrary.org/obo/DOID_6364 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_6364 http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00953 http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association http://www.w3.org/2000/01/rdf-schema#label rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old information related to usage of rizatriptan benzoate in pediatric patients 6 to 17 years old is approved for merck co inc s rizatriptan benzoate tablets however due to merck co inc s marketing exclusivity rights this drug product is not labeled with that pediatric patient 6 to 17 years old usage information limitations of use rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established if a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets is administered to treat any subsequent attacks rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine see contraindications 4 rizatriptan benzoate tablets are not indicated for the prevention of migraine attacks safety and effectiveness of rizatriptan benzoate tablets have not been established for cluster headache rizatriptan benzoate tablets are a serotonin 5 ht 1b 1d receptor agonist triptan indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age 1 limitations of use use only after clear diagnosis of migraine has been established 1 not indicated for the prophylactic therapy of migraine 1 not indicated for the treatment of cluster headache 1 http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00953 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#provenance http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#pubinfo http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#sig http://purl.org/nanopub/x/hasSignature SHw4CdNO17XpNsd8dH0OWSlo+yxnKyXDFY0A2WNUCTJkmDlFZtZ7/6hoMxWY1umKWNcZArozuz+XHIGjXpFAd7EjbJ/VWiVTph8hDPlk8Dt0HD+NqK/VX3dIw5vOuiE6Ulv0Sbtl/sRapEBFcS8RjlUG/mijDIOZdjs4AmZFDuY= http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow http://purl.org/dc/terms/created 2021-06-14T08:58:30.606+02:00 http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAAVjkZUGQw_h9YsWB6YJJMp77wtrQPR1eAXXP6VqlYow https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs